Health Invest Partners Ab Summit Therapeutics Inc. Transaction History
Health Invest Partners Ab
- $221 Million
- Q2 2025
A detailed history of Health Invest Partners Ab transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 92,737 shares of SMMT stock, worth $2.13 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
92,737
Previous 105,077
11.74%
Holding current value
$2.13 Million
Previous $2.03 Million
2.62%
% of portfolio
0.89%
Previous 0.94%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
239Shares Held
87.2MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$560 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$267 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$181 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$150 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$111 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.61B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...